Ren Xiaoqiang
- Hepatology top 5%
- Hepatitis C virus research 8
- Epidemiology top 10%
- Hepatitis B Virus Studies 9
- Liver Disease Diagnosis and Treatment 6
- Cytomegalovirus and herpesvirus research 2
-
- Sarcoma Diagnosis and Treatment 1
-
- Public-Private Partnership Projects 1
-
- Plant Gene Expression Analysis 1
-
- Cancer Mechanisms and Therapy 1
- Journals
- SHILAP Revista de lepidopterología (2 papers)Clinica Chimica Acta (1 paper)Journal of Gastroenterology (1 paper)
In The Last Decade
Ren Xiaoqiang
14 papers receiving 374 citations
Peers
Comparison fields: 5 of 40
- Hepatology 290
- Epidemiology 306
- Cancer Research 45
- Infectious Diseases 44
- Pharmacology 9
Countries citing papers authored by Ren Xiaoqiang
This map shows the geographic impact of Ren Xiaoqiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ren Xiaoqiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ren Xiaoqiang more than expected).
Fields of papers citing papers by Ren Xiaoqiang
This network shows the impact of papers produced by Ren Xiaoqiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ren Xiaoqiang. The network helps show where Ren Xiaoqiang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ren Xiaoqiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2021 | 1 | |
| 3 | 2020 | 4 | |
| 4 | 2016 | 50 | |
| 5 | 2011 | 33 | |
| 6 | 2010 | 76 | |
| 7 | 2010 | 41 | |
| 8 | 2010 | 60 | |
| 9 | 2010 | 51 | |
| 10 | 2010 | 34 | |
| 11 | 2010 | 2 | |
| 12 | Hepatitis B virus in tenofovir-naive Chinese patients with chronic hepatitis B contains no mutation of rtA194T conferring a reduced tenofovir susceptibility. | 2009 | 20 |
| 13 | 2008 | 1 | |
| 14 | [Quantitative detection of hepatitis B virus covalently closed circular DNA in sera of chronic hepatitis B patients with a newly established assay]. | 2008 | 2 |
About Ren Xiaoqiang
Ren Xiaoqiang is a scholar working on Hepatology, Epidemiology and Hematology, having authored 14 papers that have together received 376 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (9 papers), Hepatitis C virus research (8 papers), Liver Disease Diagnosis and Treatment (6 papers), Cytomegalovirus and herpesvirus research (2 papers), Sarcoma Diagnosis and Treatment (1 paper), Public-Private Partnership Projects (1 paper), Plant Gene Expression Analysis (1 paper) and Cancer Mechanisms and Therapy (1 paper). The work is most often cited by research in Hepatology (290 citations), Epidemiology (306 citations) and Cancer Research (45 citations). Ren Xiaoqiang has collaborated with scholars based in China, France and Hong Kong. Frequent co-authors include Yanwei Zhong, Dongping Xu, Fabien Zoulim, Panyong Mao, Zhihui Xu, Zhikai Xu, Shiyong Xin, Liqing Zhou, Kaixuan Chen and Ziran Xu. Their work appears in journals such as SHILAP Revista de lepidopterología, Clinica Chimica Acta and Journal of Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.